GENFIT names Larue executive VP, biomarkers

Wednesday, October 19, 2011 10:30 AM

GENFIT, a biopharmaceutical company, has named Dr. Catherine Larue executive vice-president, biomarkers.

Before joining GENFIT, Larue spent eleven years within the Bio-Rad group, where she occupied various management positions, ranging from an R&D department to the direction of a business unit.

“We are delighted by the arrival of Catherine Larue at GENFIT. Her experience, particularly in development, and her dynamic nature will enable us to significantly intensify our biomarker activity, for which our principal research programs are advancing rapidly and for which we expect to have numerous commercial prospects,” said Jean-François Mouney, CEO & chairman of GENFIT's management board.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs